Digital Polymerase Chain Reaction (PCR) Technology: Global Markets

Report Highlights

The global digital polymerase chain reaction (PCR) technology market totaled $425.0 million in 2017 and is estimated to reach $746.0 million by 2022, growing at a compound annual growth rate (CAGR) of 11.9% for the period of 2017-2022.

Report Includes

• 14 data tables and 7 additional tables
• An overview of the global market for digital polymerase chain reaction (PCR) technology
• Analyses of global market trends, with data from 2016, and estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
• Discussion of key manufacturers, suppliers, users, and a variety of factors influencing demand
• Relevant Patent analyses
• Comprehensive company profiles of major players in the market, including Abbott Laboratories, Celula Inc., Fluidigm Corp., IntegenX Inc. and Stilla Technologies

Report Scope

While this report will discuss applicable complementary technologies, it will not go into the market specifics of these complementary technologies.  Of particular note are the majority of reagents used for PCR, as there is significant overlap between the reagents used for digital PCR and those used for real-time PCR.  This report will focus on the equipment used for digital PCR, reagents specific to the technology, and any particular applications.  There will be significant discussion of the end users, including academia, industry, clinical laboratories, and other users.

Analyst Credentials

Todd Graham is an experienced scientist who has worked in a variety of settings throughout the biotechnology industry for more than 10 years as a key technical resource for a variety of businesses. Among his accomplishments are coordinating the roll out of a new test for a major clinical laboratory services provider, developing pre-clinical and clinical assays in support of pharmaceuticals and medical devices, and being a key team member in developing novel technologies for molecular diagnostics.